Objective Mcule.com aims to provide the best web-based drug discovery platform for pharmaceutical researchers (big companies, contract research organisations and academics). We aim to create an easily searchable chemical database of 500 million purchasable compounds, the Ultimate database. The Ultimate database would be primarily based on virtual (not yet synthesized, but predicted to be synthesizable) compounds. Such a large chemical space would present a major advantage for pharma and biotech companies by increasing their chances to effectively identify novel compounds, reducing their costs and time losses. This development will increase our market share and promote our growth. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverynatural sciencescomputer and information sciencesdatabasesmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) SMEInst-02-2016-2017 - Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-1-2016-2017 Funding Scheme SME-1 - SME instrument phase 1 Coordinator MCULE.COM KFT Net EU contribution € 50 000,00 Address Bartok bela ut 105-113 1115 Budapest Hungary See on map Region Közép-Magyarország Budapest Budapest Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
